Developing Strategies to Ensure Patent Protection of Medical Devices During Product Launches in Europe and the U.S.

October 16, 2018 3:30pm

Sascha Roeder
IP Manager
PARI Pharma GmbH

Frank Landolt
V.P IP
Ablynx N.V.

  • Reconciling IP and commercial aims for medical device products
  • Protecting IP for medical device products, features and ideas against competitors and followers during pre-launch and launch periods
  • Ensuring freedom-to-operate (FTO) and adhering to an IP portfolio strategy
  • Creating value for your company through strategic IP protections and possible cooperation
  • Case study on ensuring IP protection during a product launch:
    • Using the example of a new vibrating membrane nebulizer device